Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies-Reference-Cited by-同舟云学术

Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies

Published:2012-07-02 Issue:1 Volume:28 Page:61-70
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Bezard Erwan,Yue Zhenyu¹,Kirik Deniz²,Spillantini Maria Grazia³

Affiliation:

1. Departments of Neurology and Neuroscience; Friedman Brain Institute; Mount Sinai School of Medicine; New York; New York; USA

2. Brain Repair And Imaging in Neural Systems Unit; Department of Experimental Medical Science; Lund University; Lund; Sweden

3. Cambridge Center for Brain Repair; Department of Clinical Neurosciences; University of Cambridge; Cambridge; United Kingdom

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference112 articles.

1. New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline;Gerlach;J Neural Transm,1996

2. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease;Gerlach;Eur J Pharmacol,1991

3. The MPTP-treated mouse as a model of parkinsonism: how good is it?;Heikkila;Neurochem Int,1991

4. Animal models of parkinsonism using selective neurotoxins: clinical and basic implications;Zigmond;Int Rev Neurobiol,1989

5. A tale on animal models of Parkinson's disease;Bezard;Mov Disord,2011

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease;Experimental Neurology;2024-04

2. Role of Animal Models in Parkinson's Disease (PD): What Role They Play in Preclinical Translational Research;CNS & Neurological Disorders - Drug Targets;2024-02

3. Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging;Scientific Reports;2024-01-30

4. The Role of Calcium and Iron Homeostasis in Parkinson’s Disease;Brain Sciences;2024-01-17

5. Neuroprotective efficacy of melatonin in the pathophysiology of neurodegenerative disorders;Natural Molecules in Neuroprotection and Neurotoxicity;2024